Eric Small
Internal Medicine · Ucsf Medical Group Business Services
Credentials: · ·
History
Research
Sipuleucel-T immunotherapy for castration-resistant prostate cancer
New England Journal of Medicine · 2010 · 4,436 citations
New England Journal of Medicine · 2004 · 3,019 citations
Abiraterone in metastatic prostate cancer without previous chemotherapy
New England Journal of Medicine · 2013 · 2,325 citations
- CR
82 papers
80 papers · 5 as a resident
Felix Feng
62 papers
- MS
55 papers
43 papers
- CH
42 papers
- MM
41 papers
- NV
41 papers
Grants
- 2025–2030
National Cancer Institute · P01
Project lead · $529.2K · University of Wisconsin-Madison
- 2024–2029
UCSF Specialized Programs of Research Excellence (SPOREs) in Prostate Cancer
National Cancer Institute · P50
Contact PI · $6.6M · University of California, San Francisco
- 1999–2028
National Cancer Institute · P30
Project lead · $6.8M · University of California, San Francisco
- 2008–2014
Predictive Markers in Metastatic Renal Cancer
National Cancer Institute · R01
Contact PI · $511.7K · University of California, San Francisco
Clinical trials
- 2013–2020
Radiologically Guided Biopsies of mCRPC
Principal investigator · Completed
University of California, San Francisco
- 2007–2014
Principal investigator · Completed · Phase 2
University of California, San Francisco
- 2004
Principal investigator · Completed · Phase 1
AstraZeneca
- 2003–2012
Ipilimumab and Sargramostim in Treating Patients With Metastatic Prostate Cancer
Principal investigator · Completed · Phase 1
National Cancer Institute (NCI)